Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Fennec Pharmaceuticals Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 90 | 2 | 105 | +17 |
| Shares | 16.2M | 1.07K | 16.3M | +114.0K (+0.7%) |
| Value | $99.6M | $6.59K | $175.1M | +$75.4M (+75.7%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (25)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (8)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Southpoint Capital Advisors LP | 2,744,741 | $16.9M |
| Gendell Jeffrey L | 83,024 | $510.6K |
| Globeflex Capital L P | 18,343 | $112.8K |
| HighTower Advisors, LLC | 14,960 | $92.0K |
| Federated Hermes, Inc. | 2,401 | $14.8K |
| State of Wyoming | 233 | $1.43K |
| MAI Capital Management | 18 | $111 |
| Wealth Preservation Advisors, LLC | 5 | $31 |
Not filed for Q2 2026 yet (2)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 1,063 | $6.54K |
| Sunbelt Securities, Inc. | 9 | $55 |